Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Immunoprecise Antibodies Ltd. V.IPA

Alternate Symbol(s):  IPA

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:IPA)

Fundamentals Snapshot (TSXV:IPA)

Current News (TSXV:IPA)

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

Business Wire May 9, 2022

IPA's Advanced PolyTope® TATX-03, a Multi-Antibody Cocktail, Potently Prevents In Vitro Infection of Cells by the Currently Dominant Omicron Sublineage BA.2, in Addition to all Other Variants of Concern

Business Wire April 20, 2022

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

Business Wire April 14, 2022

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

Business Wire March 29, 2022

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2022

Business Wire March 16, 2022

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

Business Wire March 14, 2022

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

Business Wire March 9, 2022

ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial Results and Recent Business Highlights Conference Call for Wednesday, March 16th at 10:30 a.m. ET

Business Wire March 8, 2022

Immunotherapeutic PolyTope® from ImmunoPrecise (IPA) Potently Neutralizes the SARS-CoV-2 Omicron Variant - Moves Towards FDA/IND-Submission

Business Wire January 31, 2022

Opinion & Analysis (TSXV:IPA)

No current opinion is available.

Bullboard Posts (TSXV:IPA)

RE:IPA new investor presentation just released

You can lead a horse to water!
wallpaper2 - 23 hours ago

IPA new investor presentation just released

https://www.immunoprecise.com/wp-content/uploads/2022/07/IPAOVERVIEWJULY2022.pdf
Vancgatekeeper - 3 days ago

RE:Mid June

Im adding , cheap prices under $7 wont last long- excited for Biostand A.I updates also! IPA fiscal 2023 started May 1st, Billion dollar...
Vancgatekeeper - June 2, 2022

Mid June

New data on the POLY TOPE vaccin in mid June and submission to the FDA for approval to clinical trials this Fall,I'm adding at the...
Dragon1 - June 2, 2022

MAY Monthly Hammer Candle !

Stock closed above 20,50,100,150 and close to 200 today, add sexy monthly hammer candle.. JUNE TO REMEMBER! $25-$35 target to end 2022...
Vancgatekeeper - May 31, 2022

Monkey Pox

Do you think IPA has had the time to produce a antibody for this? They have been able to offer their partner Pharmas a "30 day...
wallpaper2 - May 23, 2022